The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Peyronie’s disease: pharmacological treatments and limitations
Abstract
Introduction: Peyronie’s disease (PD) is a disorder of the tunica albuginea from disordered and excessive deposition of collagen resulting in a palpable scar, pain, erect penile deformity and erectile dysfunction that significantly impacts patients both physically and emotionally.Areas Covered: Several treatment options have been described for PD, including shockwave therapy, traction therapy, both oral and intralesional pharmacological options, and surgery. This review seeks to examine the data for different types of non-surgical treatments for PD. We review how various treatment modalities impact several relevant clinical endpoints for Peyronie’s disease, including effects on pain, penile curvature, plaque formation, and erectile function. We performed a literature search using PubMed and SCOPUS while referencing AUA, EAU, and CUA guidelines for management of Peyronie’s Disease for studies published 1980–2020.Expert opinion: Intralesional collagenase injections have the strongest evidence and are the only FDA approved intralesional treatment for PD. Penile traction therapy (PTT) is low risk and may be beneficial in patients willing to invest significant time using the devices. Furthermore, oral combination therapy with other modalities may provide some benefit. Further investigation is required to better understand pathophysiology of PD and clarify the therapeutic utility of existing treatments, potentially with a multimodal strategy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Penile traction therapy is a nonsurgical treatment option for PD that involves applying consistent traction forces to gradually straighten penile curvature and improve symptoms.133”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [133]
In the citing paper
“Pentoxifylline, an antifibrotic agent, modulates fibrosis by suppressing inflammation, inhibiting TGF-β activation, and reducing collagen synthesis.133”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [133]
In the citing paper
“Common treatment methods for penile induration include medication therapy, injection therapy, and surgical treatment.133,147,148”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [133]
Citations
Cites
1 retracted
- Retracted
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Pathways of Protein Secretion in Eukaryotes
Kelly, R. B. (1985) · Science · doi:10.1126/science.2994224 · Cited by 1,052
Extracorporeal shockwave therapy in musculoskeletal disorders
Wang, C.-J. (2012) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-7-11 · Cited by 527
Gelbard, M., Goldstein, I., Hellstrom, W. J. G., McMahon, C. G., Smith, T., Tursi, J., Jones, N., Kaufman, G. J., & Carson, C. C. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.087 · Cited by 466
Peyronie’s Disease: AUA Guideline
Nehra, A., Alterowitz, R., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., McVary, K. T., Miner, M. M., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.05.098 · Cited by 416
Colletta, A., Wakefield, L., Howell, F., van Roozendaal, K., Danielpour, D., Ebbs, Sr., Sporn, M., & Baum, M. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.307 · Cited by 318
EAU guidelines on penile curvature
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., Vardi, Y., & Wespes, E. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.040 · Cited by 309 · cited 2×
“direct force on the plaque, leading to mechanical induced remodeling and plaque lysis, and also promotes angiogenesis, leading to increased availability of inflammatory mediators causing plaque lysis and absorption [30,33].”
BackgroundThe Incidence of Peyronie’s Disease in Rochester, Minnesota, 1950 through 1984
Lindsay, M. B., Schain, D. M., Grambsch, P., Benson, R. C., Beard, C. M., & Kurland, L. T. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37988-0 · Cited by 265
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0684 · Cited by 234
Research works printed but not linked: 7
- Androutsos G., 2002, Prog Urol, 12, 527
- Dibenedetti DB, 2011, Adv Urol, 282503, 2011
- Bellorofonte C, 1989, Arch Ital Urol Nefrol Androl, 61, 417
- Bella AJ, 2018, Can Urol Assoc J, 12, 2018
- Scroppo FI, 2001, Int J Impot Res, 13
- Pavan A, 2020, StatPearls [Internet]
- Vacante F, 2018, J UDiabetes Res, 4028297, 2018
Cited by
Chi, J., Bi, W., Lou, K., Ma, J., Wu, J., & Cui, Y. (2024) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeae006 · Cited by 14
KARAKOSE, A., & YİTGİN, Y. (2024) · Minerva Urology and Nephrology · doi:10.23736/s2724-6051.23.05458-7 · Cited by 11
Metadata
- Authors
- Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A.
- Affiliations
- Northwestern University (US)
- Rush University Medical Center (US)
- Cleveland Clinic (US)
- Corresponding author
- Amarasekera, Channa
- ORCID
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2021-03-25
- Volume
- 14
- Issue
- 6
- Pages
- 703-713
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W3136796051
- Cited by
- 24
- References
- 89
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 11 · 2023: 7 · 2022: 2
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- Peyronie's disease, penile traction therapy, shock wave therapy, oral combination therapy, penile curvature, erectile dysfunction, penile pain, tunica albuginea, collagen deposition, conservative treatment
- MeSH terms
- Extracorporeal Shockwave Therapy, Animals, Combined Modality Therapy, Humans, Male, Penile Induration, Traction, Injections, Intralesional, Collagenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peyronie’s disease: pharmacological treatments and limitations. https://app.cochat.ai/papers/10.1080/17512433.2021.1903873
- The paper
- Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021). Peyronie’s disease: pharmacological treatments and limitations. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2021.1903873
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.